October 22, 2016
1 min read
Save

Radiation Oncology Institute awards two grants

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The Radiation Oncology Institute selected two researchers to receive Innovative Projects in Radiation Oncology grant awards.

The awards, which total nearly $100,000, will fund research into how physicians can use real-tie monitoring and feedback capability of smart technologies to improve outcomes for patients with cancer.

Geoffrey V. Martin, MD, a fourth-year radiation oncology resident at The University of Texas MD Anderson Cancer Center, received a grant to add patient-reported quality-of-life measures to a clinical trial that will assess the use of smartphone-connected technology for outpatient monitoring of patients with lung cancer who are undergoing radiation therapy.

Nitin Ohri, MD, assistant professor of radiation oncology at Montefiore Medical Center and Albert Einstein College of Medicine, received a grant to conduct a randomized trial that will determine whether a pedometer-based walking program can decrease treatment interruptions and improve outcomes among patients with cancer who receive concurrent chemotherapy and radiation therapy.

“[The Radiation Oncology Institute] focuses on funding practical research that addresses the most clinically relevant questions and immediate needs for radiation oncologists and their patients,” institute president Deborah A. Kuban, MD, FASTRO, said in a press release. “These two innovative research projects have clear potential to improve the lives of cancer patients by applying technology that we use every day.”

The Radiation Oncology Institute is a nonprofit foundation created by the American Society for Radiation Oncology to support research and education initiatives that enhance the role of radiation therapy for the treatment of cancer.